134 related articles for article (PubMed ID: 8980399)
21. Non-RI protocols for L-myc allelotyping and deletion mapping of chromosome 1p in primary lung cancers.
Hiyama K; Mendoza C; Hiyama E
Methods Mol Med; 2003; 74():231-9. PubMed ID: 12415698
[No Abstract] [Full Text] [Related]
22. p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.
Liloglou T; Ross H; Prime W; Donnelly RJ; Spandidos DA; Gosney JR; Field JK
Br J Cancer; 1997; 75(8):1119-24. PubMed ID: 9099958
[TBL] [Abstract][Full Text] [Related]
23. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer.
Tseng RC; Chang JW; Hsien FJ; Chang YH; Hsiao CF; Chen JT; Chen CY; Jou YS; Wang YC
Int J Cancer; 2005 Nov; 117(2):241-7. PubMed ID: 15900585
[TBL] [Abstract][Full Text] [Related]
24. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer.
Hsieh YS; Lee YL; Yang SF; Yang JS; Chen W; Chen SC; Shih CM
Lung Cancer; 2007 Nov; 58(2):191-5. PubMed ID: 17688968
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability at chromosome 8p in non-small cell lung cancer is associated with lymph node metastasis and squamous differentiation.
Woenckhaus M; Stoehr R; Dietmaier W; Wild PJ; Zieglmeier U; Foerster J; Merk J; Blaszyk H; Pfeifer M; Hofstaedter F; Hartmann A
Int J Oncol; 2003 Nov; 23(5):1357-63. PubMed ID: 14532977
[TBL] [Abstract][Full Text] [Related]
26. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
27. LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma.
Strazisar M; Mlakar V; Glavac D
Lung Cancer; 2009 Jun; 64(3):257-62. PubMed ID: 19008013
[TBL] [Abstract][Full Text] [Related]
28. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.
Hung J; Kishimoto Y; Sugio K; Virmani A; McIntire DD; Minna JD; Gazdar AF
JAMA; 1995 Feb; 273(7):558-63. PubMed ID: 7837389
[TBL] [Abstract][Full Text] [Related]
29. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Cancer Res; 1995 Jan; 55(2):220-3. PubMed ID: 7812947
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
[TBL] [Abstract][Full Text] [Related]
31. Detection of loss of heterozygosity by high-resolution fluorescent system in non-small cell lung cancer: association of loss of heterozygosity with smoking and tumor progression.
Yoshino I; Fukuyama S; Kameyama T; Shikada Y; Oda S; Maehara Y; Sugimachi K
Chest; 2003 Feb; 123(2):545-50. PubMed ID: 12576379
[TBL] [Abstract][Full Text] [Related]
32. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer.
Uchiyama M; Usami N; Kondo M; Mori S; Ito M; Ito G; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Minna JD; Shimokata K; Sekido Y
Int J Cancer; 2003 Dec; 107(6):962-9. PubMed ID: 14601056
[TBL] [Abstract][Full Text] [Related]
34. Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma.
Mendes-da-Silva P; Moreira A; Duro-da-Costa J; Matias D; Monteiro C
Mol Pathol; 2000 Aug; 53(4):184-7. PubMed ID: 11040940
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
[TBL] [Abstract][Full Text] [Related]
37. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.
Froudarakis ME; Sourvinos G; Fournel P; Bouros D; Vergnon JM; Spandidos DA; Siafakas NM
Chest; 1998 Apr; 113(4):1091-4. PubMed ID: 9554652
[TBL] [Abstract][Full Text] [Related]
40. Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
Shipman R; Schraml P; Colombi M; Ludwig CU
Int J Oncol; 1998 Jan; 12(1):107-11. PubMed ID: 9454893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
